Overview

Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients

Status:
Recruiting
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
Comparison outcomes of a large cohort of moderate and severe COVID-19 patients received remdesivir alone with patients who received remdesivir in combination with lopinavir/ ritonavir in addition to standard management.
Phase:
Phase 4
Details
Lead Sponsor:
Ahmed Essam
Collaborator:
Beni-Suef University
Treatments:
Lopinavir
Remdesivir
Ritonavir